LEADER 01158nam0-22003851i-450- 001 990006809750403321 005 20110708141253.0 035 $a000680975 035 $aFED01000680975 035 $a(Aleph)000680975FED01 035 $a000680975 100 $a20010426d--------km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay-------001yy 200 1 $aRoma al femminile$fA cura di A. Fraschetti$fFranca Ela Consolino, Augusto Fraschetti, Andrea Giardina ... [et al.]$ga cura di A. Fraschetti 210 $aRoma ; Bari$cLaterza$d1994 215 $aXX, 292 p.$d20 cm 225 1 $aStoria e società 610 0 $aDonne celebri - Roma antica 610 0 $aDonna - Posizione sociale - Roma antica 676 $a920.72 702 1$aFraschetti,$bA. 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006809750403321 952 $aCOLL.405(73)$bBibl.21040$fFLFBC 952 $aXII C 73$b24687$fFSPBC 952 $a920.72 FRA 1$bBibl.21040$fFLFBC 952 $aDDR-XXVII B 032.3$b2624 ddr$fDDR 959 $aFSPBC 959 $aFLFBC 959 $aDDR 996 $aRoma al femminile$9633397 997 $aUNINA LEADER 01212nam--2200409---450- 001 990002783430203316 005 20081204124447.0 010 $a88-13-25380-X 035 $a000278343 035 $aUSA01000278343 035 $a(ALEPH)000278343USA01 035 $a000278343 100 $a20060718d2004----km-y0itay0103----ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $a<> activity-based costing in atto$emetodo, progettazione, implementazione$fMassimiliano Zanigni 210 $aPadova$cCEDAM$d2004 215 $aXVI, 200 p.$d24 cm 410 0$12001 454 1$12001 606 0 $aAziende$xGestione 676 $a658.1552 700 1$aZANIGNI,$bMassimiliano$0573795 801 0$aIT$bsalbc$gISBD 912 $a990002783430203316 951 $aP07 718$bDISTRA 951 $a658.15 ZAN 1 (IRA 6 1078)$b15125 E.C.$cIRA 6$d00063780 959 $aBK 969 $aDISTRA 969 $aECO 979 $aDISTRA1$b90$c20060718$lUSA01$h1131 979 $aALESSANDRA$b90$c20071127$lUSA01$h0951 979 $aALESSANDRA$b90$c20071127$lUSA01$h0951 979 $aRSIAV1$b90$c20081204$lUSA01$h1244 996 $aActivity-based costing in atto$9996435 997 $aUNISA LEADER 01069nam0-22003251i-450- 001 990006093640203316 005 20161005134626.0 035 $a000609364 035 $aUSA01000609364 035 $a(ALEPH)000609364USA01 035 $a000609364 100 $a20151029a19159999---y0itay0103----ba 101 0 $aita 102 $aIT 200 1 $a<> doveri del cittadino in tempo di guerra$fGiovanni Calò 210 $aMilano$cRavà & C.$d1915 215 $a32 p.$d18 cm 610 0 $aGuerra mondiale <1914-1918> 700 0 $aCALO',$bGiovanni$0342354 801 0$aIT$bAtlantis$gRICA$2UNIMARC 856 4 $uhttp://hdl.handle.net/10556/1798$4.$zEleA - Archivio aperto dell'Università degli studi di Salerno 912 $a990006093640203316 951 $aXV.2.MISC. 286$b7524 F.C.$cXV.2.MISC.$d00140782 959 $aBK 969 $aCUOMO 979 $aMARIAS$b90$c20151029$lUSA01$h1249 979 $aMARIAS$b90$c20161005$lUSA01$h1322 979 $aMARIAS$b90$c20161005$lUSA01$h1346 996 $aDoveri del cittadino in tempo di guerra$91383027 997 $aUNISA LEADER 01470nam 2200445 450 001 9910717341403321 005 20210615130437.0 035 $a(CKB)4100000011134515 035 $a(OCoLC)1256584981 035 $a(EXLCZ)994100000011134515 100 $a20210615d2020 ua 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHow dependents affect federal income taxes 210 1$a[Washington, D.C.] :$cCongress of the United States, Congressional Budget Office,$d2020. 215 $a1 online resource (31 pages, 1 unnumbered page) $cillustrations 300 $a"January 2020." 300 $a"Shannon Mok prepared the report"--About this document page. 320 $aIncludes bibliographical references. 606 $aIncome tax$zUnited States 606 $aIncome tax$xLaw and legislation$zUnited States 606 $aTaxation$zUnited States 606 $aFamily policy$zUnited States 606 $aDependents$zUnited States 615 0$aIncome tax 615 0$aIncome tax$xLaw and legislation 615 0$aTaxation 615 0$aFamily policy 615 0$aDependents 700 $aMok$b Shannon$01389405 712 02$aUnited States.$bCongressional Budget Office, 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910717341403321 996 $aHow dependents affect federal income taxes$93475903 997 $aUNINA LEADER 02227oam 2200505 450 001 9910827810503321 005 20190911103508.0 010 $a1-4166-2254-3 010 $a1-4166-2253-5 035 $a(OCoLC)961187767 035 $a(MiFhGG)GVRL7360 035 $a(EXLCZ)993710000000851993 100 $a20160627h20162016 uy 0 101 0 $aeng 135 $aurun|---uuuua 181 $ctxt 182 $cc 183 $acr 200 14$aThe artisan teaching model for instructional leadership $eworking together to transform your school /$fKenneth Baum, David Krulwich 210 1$aAlexandria, VA USA :$cASCD,$d[2016] 210 4$d?2016 215 $a1 online resource (xvi, 137 pages) $cillustrations 225 0 $aGale eBooks 300 $aDescription based upon print version of record. 311 $a1-4166-2251-9 320 $aIncludes bibliographical references and index. 327 $aIntroduction: A School Built with a New Vision; 1: The Foundation; PART I: The Artisan Teaching Model; 2: The Elements of Expertise: Who Are the Leaders?; 3: Collaboration in the Artisan Teaching Model; 4: The Effects of the Artisan Teaching System; 5: The Leadership Pipeline; PART II: Customizing and Implementing the Artisan Teaching Model; 6: Customizing the Model to Fit Any School; 7: Implementation Strategies: Where to Start?; 8: Strategies for Hiring; Epilogue: How Did We Get Here?; References; Index; About the Authors 330 $aIntensive collaboration among teachers helps develop the broad range of skills they need to become true artisans who know how to help every student achieve. 606 $aMotivation in education 606 $aEffective teaching 606 $aEducational leadership 606 $aSchool improvement programs 615 0$aMotivation in education. 615 0$aEffective teaching. 615 0$aEducational leadership. 615 0$aSchool improvement programs. 676 $a371.102 700 $aBaum$b Kenneth$01645360 702 $aKrulwich$b David 801 0$bMiFhGG 801 1$bMiFhGG 906 $aBOOK 912 $a9910827810503321 996 $aThe artisan teaching model for instructional leadership$93991767 997 $aUNINA LEADER 02270nam 2200421 450 001 9910824150003321 005 20200520144314.0 010 $a1-57799-628-3 035 $a(CKB)3790000000535922 035 $a(MiAaPQ)EBC5153186 035 $a(Au-PeEL)EBL5153186 035 $a(CaPaEBR)ebr11472447 035 $a(OCoLC)1013823420 035 $a(EXLCZ)993790000000535922 100 $a20190123d2015 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aLive in liberty $ethe spiritual message of Galatians /$fDaniel Bush & Noel Due ; foreword by Steve Brown 210 1$aBellingham, WA :$cLexham Press,$d[2015] 210 4$d©2015 215 $a1 online resource (xxvi, 323 pages) 300 $aIncludes index. 311 $a1-57799-629-1 330 $aA systemic problem plagues the local and global church: we habitually lose the gospel. The gospel has been equated with everything from personal prosperity to laws for virtuous living. But all such perceptions paralyze the mission of the church, which is aimed at finding true abundant and joyful life in Christ. In Galatians, the Apostle Paul engages in a passionate defense of the gospel. It may be a short book, but the consequences of its teaching are truly enormous. Martin Luther found such joy and peace in its pages that he said, "The Epistle to the Galatians is my epistle. To it I am as it were in wedlock. It is my Katherine"--Luther's beloved wife. The critical message of Galatians takes us into the heart of an experience--the enjoyment of God's presence and everlasting peace--one which sets us free to love and be loved. In Live in Liberty, Daniel Bush and Noel Due bring out the spiritual message of Paul's words, helping you apply it to your mind and soul so that you may experience the liberating presence of God. Also included is a study guide by Lee Beckham.--Publisher description. 676 $a227.406 700 $aBush$b Daniel$01682263 702 $aDue$b Noel 702 $aBrown$b Steve 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910824150003321 996 $aLive in liberty$94052262 997 $aUNINA LEADER 07228nam 2202161z- 450 001 9910557129103321 005 20210501 035 $a(CKB)5400000000040763 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68429 035 $a(oapen)doab68429 035 $a(EXLCZ)995400000000040763 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAnticancer Agents$eDesign, Synthesis and Evaluation 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (606 p.) 311 08$a3-0365-0140-1 311 08$a3-0365-0141-X 330 $aThis book is a printed edition of the Special Issue entitled "Anticancer Agents: Design, Synthesis and Evaluation" that was published in Molecules. Two review articles and thirty research papers are included in the Special Issue. Three second-generation androgen receptor antagonists that have been approved by the U.S. FDA for the treatment of prostate cancer have been reviewed. Identification of mimics of protein partners as protein-protein interaction inhibitors via virtual screening has been summarized and discussed. Anticancer agents targeting various protein targets, including IGF-1R, Src, protein kinase, aromatase, HDAC, PARP, Toll-Like receptor, c-Met, PI3Kdelta, topoisomerase II, p53, and indoleamine 2,3-dioxygenase, have been explored. The analogs of three well-known tubulin-interacting natural products, paclitaxel, zampanolide, and colchicine, have been designed, synthesized, and evaluated. Several anticancer agents representing diverse chemical scaffolds were assessed in different kinds of cancer cell models. The capability of some anticancer agents to overcome the resistance to currently available drugs was also studied. In addition to looking into the in vitro ability of the anticancer agents to inhibit cancer cell proliferation, apoptosis, and cell cycle, in vivo antitumor efficacy in animal models and DFT were also investigated in some papers. 517 $aAnticancer Agents 606 $aMedicine and Nursing$2bicssc 610 $a1,2,3-triazole 610 $a2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide 610 $a3,6-dibromocarbazole 610 $a4-(pyridin-4-yloxy)benzamide 610 $a5-bromoindole 610 $a5-fluorouracil 610 $aABCB1 (P-glycoprotein) 610 $aactin 610 $aADME 610 $aallene 610 $aamides/esters 610 $aandrogen receptor 610 $aanti-cancer activity 610 $aanti-neuroinflammation 610 $aanti-ovarian cancer 610 $aanti-tumor 610 $aanticancer 610 $aanticancer activity 610 $aanticancer agent 610 $aanticancer agents 610 $aanticancer compounds 610 $aantimitotic agents 610 $aantioxidant activity 610 $aantiproliferative activity 610 $aantiproliferative agent 610 $aantitumor 610 $aantitumor activity 610 $aapalutamide 610 $aapoptosis 610 $aaromatase 610 $abenzimidazole 610 $abenzofuran-pyrazole 610 $abenzofurans 610 $abeta-lapachone 610 $abivalency 610 $abreast cancer 610 $ac-Met 610 $acarbazole 610 $acell cycle 610 $achemical synthesis 610 $achemoresistance 610 $achrysin analogues 610 $acolchiceine 610 $acolchicine amide 610 $acolchicine analogs 610 $acolchicine sulfonamide 610 $acolon cancer 610 $acomputational docking 610 $acoumarin 610 $acrystal structure 610 $acyanopyridone 610 $acytotoxic activity 610 $acytotoxic properties 610 $acytotoxicity 610 $adarolutamide 610 $aDFT study 610 $adihydroartemisinin 610 $adihydropyranoindole 610 $adocking 610 $adocking studies 610 $adrug discovery 610 $adrug resistance 610 $aE-stereoselective 610 $aenzalutamide 610 $aenzyme inhibition 610 $aestrone derivatives 610 $aflavonoid 610 $aflavonoids 610 $agemcitabine 610 $aHDAC inhibitors 610 $aHeLa 610 $aHepG2 610 $ahydrates 610 $ahydrazine 610 $aIGF-1R 610 $aIL-12 610 $aimmune modulation 610 $aindoleamine 2,3-dioxygenase 610 $ainflammation 610 $ainhibitor 610 $aK562 610 $akinase inhibitor 610 $aMCF-7 610 $aMDM2-p53 interaction 610 $amigration 610 $amimetics 610 $amolecular simulation 610 $aMOLT-4 610 $amultidrug resistance (MDR) reversal 610 $aN-substituted pyrazoline 610 $ananoparticles 610 $anatural product 610 $aneuroblastoma 610 $aNIH3T3 610 $ao-nitro-benzyl 610 $aorganosilicon compounds 610 $aortho-quinones 610 $aovarian cancer 610 $aovercoming drug resistance 610 $aP-glycoprotein 610 $aP-MAPA 610 $aPARP inhibitor 610 $aPARP-1 inhibition 610 $aphenylpyrazolopyrimidine 610 $aphotoactivatable protecting groups 610 $aPI3Ks 610 $aPI3K? inhibitor 610 $aPI3K? inhibitors 610 $apolyvalency 610 $aprodrug 610 $aprostate cancer 610 $aPROTACs 610 $aprotein degradation 610 $aprotein kinase 610 $aprotein-protein interactions 610 $aPyrazole 610 $apyrazolopyridine 610 $apyridotriazine 610 $aquinazolin-4(3H)-one 610 $aquinazolin-4(3H)-thione 610 $aregioselective 610 $asalinomycin 610 $aSchiff base 610 $aSILA-409 (Alis-409) 610 $aSILA-421 (Alis-421) 610 $aSrc 610 $asubstituted pyridine 610 $asynergy 610 $asynthesis 610 $aTalazoparib 610 $atanshione IIA 610 $ataxoids 610 $athiazolidinone 610 $aThienopyrimidine 610 $athienopyrimidinone 610 $athiocolchicine 610 $athiopene 610 $athioxotriazopyridine 610 $aTLR signaling 610 $atopoisomerase II inhibitor 610 $atriazolothiadiazine 610 $atriple-negative breast cancer 610 $atryptophan metabolism 610 $atubulin inhibitors 610 $atumor specificity 610 $aurea 610 $avirtual screening 610 $axanthones 610 $ayeast-based assays 610 $azampanolide 610 $a?III-tubulin 615 7$aMedicine and Nursing 700 $aChen$b Qiao-Hong$4edt$01313308 702 $aChen$b Qiao-Hong$4oth 906 $aBOOK 912 $a9910557129103321 996 $aAnticancer Agents$93031264 997 $aUNINA